Antiangiogenesis treatment for age-related macular degeneration;Antiangiogenesebehandling til aldersrelateret maculadegeneration

Ugeskrift for Laeger

Volumn 167, Issue 35, 2005, Pages 3267-

  Sjølie, Anne Katrin ^a   Mortensen, Kelvin Kamp ^b   Hansen, Merete H ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; PEGAPTANIB; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; APTAMER; OLIGONUCLEOTIDE;

AGING; ANGIOGENESIS; EDITORIAL; HUMAN; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; AGED; DRUG ANTAGONISM; DRUG EFFECT; INJECTION; VITREOUS BODY;

AGED; ANGIOGENESIS INHIBITORS; APTAMERS, NUCLEOTIDE; HUMANS; INJECTIONS; MACULAR DEGENERATION; OLIGONUCLEOTIDES; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITREOUS BODY;

EID: 24144487186     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (2)

1. Larsen M, Sander B, Villumsen JE et al. Behandling af neovaskulær aldersrelateret maculadegeneration med intravitreal vaskulær endotelial vækstfaktorhæmmer. Ugeskr Læger 2005;167:3301-5.
2. Van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of Ocular Neovascularization. Promises and Potential Problems. JAMA 2005;293:1509-13.